Companies/US/NEUP

NEUPHORIA THERAPEUTICS INC.

Ownership & governance

Proxy officers5

NameRoleSinceShares
Alan FisherDirector or executive officer2016-09-0113,658
David WilsonDirector or executive officer2016-06-016,992
Jane Ryan, Ph.DDirector or executive officer2020-10-017,243
Miles DaviesDirector or executive officer2021-07-016,909
Spyridon “Spyros” Papapetropoulos, M.DDirector or executive officer—49,267

Filing shareholders1

NameOwnershipShares
Lynx1 Capital Management LP16.20%875,328

Proxy · as of 2026-11-02

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus none
  • Hold 1

Broker actions5

FirmActionToTargetDate
HC Wainwright & Co.DowngradeNeutral—2026-05-15
HC Wainwright & Co.MaintainedBuy72025-12-05
Maxim GroupMaintainedBuy352025-09-11
HC Wainwright & Co.ReiteratedBuy212025-08-26
HC Wainwright & Co.MaintainedBuy212025-02-04

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers